In conclusion, in this study we show that c-Myc can be considered a molecule at the cross-road between UPR and DDR in correlation with its capacity to cross-talk with the IRE1α/XBP1 arm of UPR, as observed in these hematological malignancies. The gene discussed is MYC; the disease is hematologic disorder.